Fidelity Investments’s Immix Biopharma IMMX Stock Holding History
Bought
Maintained
Sold
Other funds holding IMMX
SVCM
OM
Fidelity Investments's IMMX Position: Q3 2026 in Review
Fidelity Investments increased its Immix Biopharma (IMMX) stake by 1,226% in Q3 2026, buying an estimated $8.47K and bringing the position to 809 shares worth $8.42K. The position accounts for ﹤0.01% of the portfolio, ranked #4987.
Fidelity Investments first reported a position in IMMX in Q3 2022 and has held it in 4 quarters since. 137 funds tracked by Wall St. Rank hold IMMX as of Q3 2026.
- Fidelity Investments held 809 shares of Immix Biopharma worth $8.42K as of Q3 2026.
- Fidelity Investments bought 748 Immix Biopharma shares in Q3 2026, an estimated $8.47K.
- Immix Biopharma made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #4987 holding.
- Fidelity Investments first reported a position in Immix Biopharma in Q3 2022 and has held it in 4 quarters since.
- 137 funds tracked by Wall St. Rank held Immix Biopharma as of Q3 2026.
Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.